NYSE - Delayed Quote USD

Quest Diagnostics Incorporated (DGX)

177.44
+1.54
+(0.88%)
At close: June 10 at 4:00:02 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
10,158,000
9,872,000
9,252,000
9,883,000
10,788,000
Cost of Revenue
6,822,000
6,628,000
6,199,000
6,450,000
6,579,000
Gross Profit
3,336,000
3,244,000
3,053,000
3,433,000
4,209,000
Operating Expense
1,944,000
1,898,000
1,791,000
2,005,000
1,828,000
Operating Income
1,392,000
1,346,000
1,262,000
1,428,000
2,381,000
Net Non Operating Interest Income Expense
-225,000
-201,000
-152,000
-138,000
-151,000
Other Income Expense
18,000
30,000
20,000
-55,000
369,000
Pretax Income
1,185,000
1,175,000
1,130,000
1,235,000
2,599,000
Tax Provision
266,000
273,000
248,000
264,000
597,000
Earnings from Equity Interest Net of Tax
29,000
19,000
26,000
44,000
78,000
Net Income Common Stockholders
892,000
866,000
850,000
942,000
1,988,000
Diluted NI Available to Com Stockholders
892,000
866,000
850,000
942,000
1,988,000
Basic EPS
8.01
7.78
7.59
8.10
15.85
Diluted EPS
7.91
7.69
7.49
7.97
15.55
Basic Average Shares
111,000
111,000
112,000
116,000
125,000
Diluted Average Shares
113,250
113,000
113,000
118,000
128,000
Total Operating Income as Reported
1,392,000
1,346,000
1,262,000
1,428,000
2,381,000
Total Expenses
8,766,000
8,526,000
7,990,000
8,455,000
8,407,000
Net Income from Continuing & Discontinued Operation
897,000
871,000
854,000
946,000
1,995,000
Normalized Income
897,000
871,000
854,000
946,000
1,995,000
Interest Income
24,000
25,000
11,000
10,000
1,000
Interest Expense
249,000
226,000
163,000
148,000
152,000
Net Interest Income
-225,000
-201,000
-152,000
-138,000
-151,000
EBIT
1,434,000
1,401,000
1,293,000
1,383,000
2,751,000
EBITDA
1,951,000
1,894,000
1,732,000
1,820,000
3,159,000
Reconciled Cost of Revenue
6,442,000
6,262,000
5,868,000
6,133,000
6,274,000
Reconciled Depreciation
517,000
493,000
439,000
437,000
408,000
Net Income from Continuing Operation Net Minority Interest
897,000
871,000
854,000
946,000
1,995,000
Normalized EBITDA
1,951,000
1,894,000
1,732,000
1,820,000
3,159,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 12/17/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LH Labcorp Holdings Inc.
259.37
+1.42%
 
WAT Waters Corporation
349.84
+0.43%
 
MTD Mettler-Toledo International Inc.
1,216.57
+1.77%
 
A Agilent Technologies, Inc.
120.52
+3.24%
 
GH Guardant Health, Inc.
50.09
+1.13%
 
VCYT Veracyte, Inc.
27.88
+0.11%
 
QGEN Qiagen N.V.
46.22
+0.11%
 
NEO NeoGenomics, Inc.
7.84
+3.70%
 
DHR Danaher Corporation
202.62
+1.72%
 
NTRA Natera, Inc.
165.22
+0.63%